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Abstract 
Introduction: Cancer treatment is a process with continuous development. The 
most common treatment, within the field of radiation physics, is external 
radiation therapy, whereas one of the least common methods is Selective Internal 
RadioTherapy (SIRT). SIRT is a rather novel method for treating liver carcinoma. 
Microspheres containing 90Y are infused directly into the liver, via the hepatic 
artery.  
 
Seventeen SIRT-treatments have been performed at Skåne University Hospital 
(SUS) in Lund since the start in December 2010 until today (June 2012).  
Due to the work of David Minarik, the activity distribution is today quantified 
post-treatment in clinical routine with the single photon emission computed 
tomography camera (SPECT) system. However, recent work performed by 
Lhommel et. al has shown the ability to use the positron emission tomography 
(PET) system to create PET-images with 90Y labeled SIR-spheres. Due to the better 
spatial resolution in the PET-camera, compared to the SPECT-camera, it is of 
interest to investigate the possibility to use PET instead of SPECT, for activity 
quantification of SIRT-patients´ liver. A system with a better spatial resolution has 
the potential to create a more accurate absorbed dose map from the activity 
distribution within the liver, compared to the SPECT based system used today. 
The aim of this thesis is to evaluate whether PET can be used for activity 
quantification after 90Y microsphere treatments. Once the most suitable camera is 
chosen, absorbed dose calculation can be performed with the outcome from the 
activity distribution shown on the PET- or SPECT -images of the liver.  
Materials and methods: For this project, three patients have been treated with 
SIRT and imaged in both the PET- and SPECT-camera. Furthermore, phantom 
measurements have been performed both with 18F and 90Y.  
Results: For all three patients the PET system overestimates the total activity in 
the liver with about 20%. The SPECT systems result vary between 0% to – 15% 
compared to the true activity within the liver. However, more corrections are 
required on the PET-images to be certain that extra counts originating from the 
crystals within the PET cameras detector, does not contaminate the image with 
background noise, and thus giving an overestimation in activity quantification of 
about 20%. 
Conclusion: The results indicate that it is possible to use PET to determine the 
activity distribution within the liver for patients treated with SIRT. However, 
further investigations are needed to determine whether PET should replace 
SPECT.  
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Populärvetenskaplig beskrivning 
En av behandlingsmetoderna mot tumörer i levern på Lunds Universitetssjukhus 
är SIRT som står för ”Selective Internal RadioTherapy” det vill säga en intern 
radioterapeutisk behandling, i detta fall specifikt för levern. Behandlingen är cirka 
tio år gammal och i Lund har den utförts sedan december 2010. Under våren 2012 
behandlades tre patienter med SIRT då de inte kan få sina cancertumörer i levern 
bortopererade av olika skäl. Ofta är det tumörerna metastaserade från en 
primärtumör i tjocktarmen och som spridit sig och bildat ett blodrikt område 
vilket därför omöjliggör operation. Även metastaser från primära 
bröstcancertumörer samt andra endokrina tumörer kan sätta sig i levern. De 
tumörformer som gagnas av SIRT-behandling är de med en välutvecklad 
blodförsörjning med många kärl. Det som utnyttjas är det faktum att tumörer (> 
20mm diameter) har en blodförsörjning som till minst 80% kommer från 
leverartären. Detta till skillnad från normal levervävnad som har sin huvudsakliga 
blodförsörjning från portavenen. Mikroskopiska sfärer (mikrosfärer) innehållande 
det radioaktiva ämnet Yttrium-90 (90Y) kan då embolisera tumörernas 
blodförsörjningskanaler.  Beta partiklarna emitterade från 90Y sönderfallet kan då 
på grund av sin förhållandevis långa räckvidd deponera energi i tumörerna.   
Behandlingen utförs med växelvisa infusioner av mikrosfärer, vatten och 
kontrastvätska. Först kontrollerar man så att flödet är normalt med 
kontrastvätska. Sedan administreras SIR-sfärer genom en kateter placerad 
intraarteriellt vid levern. Därefter fyller man på med vatten för att tömma 
kateterslangen och slutligen ger man åter kontrastvätska för att kontrollera att 
flödet ser normalt ut för vidare infusion.  
Målet med detta projekt var att absolutbestämma den aktivitet av 90Y som man 
deponerar i levern för att slå ut cancern. Fördelningen av radioaktivitet i levern 
mäter man idag genom en tomografisk undersökning (SPECT) dagen efter SIRT 
behandlingen. Syftet var då att undersöka möjligheten att kvantifiera aktiviteten 
även med en sk PET-kamera. Detta system mäter fotoner annihilerade från en 
beta plus partikel (positron). Detta är möjligt då det i 32 sönderfall per en miljon 
emitteras en positron från 90Y. Denna positron växelverkar med en elektron med 
en annihilation och efterföljande emission av två motsattriktade fotoner. En PET-
kamera är dedicerad att detektera koincidenser från dessa två fotoner med en 
hög noggrannhet. Frågeställningen var då om det är tilläcklig noggrannhet för att 
kunna aktivitetskvantifiera 90Y i levern. Frågan var också om PET-systemet är mer 
lämpat än det nuvarande SPECT-system beträffande denna mätning på grund av 
PET-systemets bättre upplösningsförmåga jämfört med SPECT. Då skulle detta 
system ge en mer korrekt bild av den absorberade dosen över levern.  
Resultaten visade att fördelningen av aktivitet var mer välbestämd med ett PET 
system än motsvarande undersökning med SPECT, detta beror sannolikt på att 
PET systemet har en bättre spatiell upplösning jämfört med SPECT. Dock fanns det 
i PET bilderna ett bakgrundsbidrag av händelser orsakade av naturlig 
radioaktivitet i själva detektormaterialet på PET systemet och som bör korrigeras 
för innan man med säkerhet kan säga hur kvantitativt noga PET bilderna 
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egentligen är.  
För de tre SIRT-patienterna i denna undersökning så visade resultaten att 
aktiviteten av 90Y överskattas med cirka 20% när man mäter i PET kameran. 
Motsvarande för SPECT visade ett intervall mellan 0 och 15%, detta jämfört med 
den sanna framräknade aktiviteten. Med andra ord så visade SPECT på en större 
säkerhet vad beträffar bestämning av den totala 90Y aktiviteten som 
administrerats i levern.  
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1. Introduction 
This project is about accurate activity quantification. Quantification is the term 
that answers the question: how much? In this project the answer is given in 
Becquerel (Bq) or Bq per milliliter (ml), the latter meaning activity concentration. 
When measuring radioactivity in a camera system it is of great concern that the 
reconstructed activity matches the true activity or activity concentration. The best 
way to test the system’s quantification accuracy is to perform phantom 
measurements with known activity concentrations or a known total activity. The 
measured versus true activity is in turn compared and presented as a quotient: 
𝑚𝑒𝑎𝑠𝑢𝑟𝑒𝑑 𝑎𝑐𝑡𝑖𝑣𝑖𝑡𝑦
𝑡𝑟𝑢𝑒 𝑎𝑐𝑡𝑖𝑣𝑖𝑡𝑦 = 𝑎𝑐𝑡𝑖𝑣𝑖𝑡𝑦 𝑟𝑎𝑡𝑖𝑜   (1) 
Further on, accurate activity quantification is necessary in order to perform a 
correct absorbed dose calculation, both locally and for a total absorbed dose 
within an organ. 
For patients with inoperable liver cancer treated with selective internal 
radiotherapy (SIRT) due to their inoperable liver cancer, activity quantification as 
well as activity localization is of great interest.  
Today SPECT imaging is performed one day after the operation and infusion of 
90Yttrium (90Y) labelled microspheres. The bremsstrahlung spectrum is analysed 
and an activity distribution can be calculated. 
An interesting alternative to SPECT bremsstrahlung imaging, is to use Positron 
emission tomography (PET). This is performed by imaging annihilation photons 
emitted from the 32 ppm of the decays from the 90Y that result in an emission of a 
positron. If sufficient number of positrons from the 90Y is registered as a true 
coincidence, an image can be created.  
 
PET is widely used to localize tumours because of high contrast and high spatial 
resolution. The contrast property is utilized when searching for tumours in a 
patient and is measured in standardized uptake ratio (SUV). SUV is the 
concentration in a tumour normalized to the total administered activity per body 
weight (assuming that weight is represented by the volume).  
Novel work performed by Lhommel et. al [1, 2] has shown the ability to use the 
PET -system to create images with 90Y labelled SIR-spheres. 
Image quality is important when comparing the PET and SPECT system. Contrast, 
spatial resolution and system sensitivity are parameters important for the image 
which is about to be analysed. A poor spatial resolution can lead to misplacement 
and spread out of counts from the radioactivity imaged, and an insufficient 
contrast can make the uptake areas difficult to visualize relative the background.  
Which of the two camera systems, PET or SPECT, that creates the most accurate 
activity quantification of 90Y is yet to be determined.  
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2. Background  
When irradiating 89Yttrium with neutrons the isotope90Y can be created. Figure 1 
shows the decay scheme [3]. 
90Y mainly decays by beta emission but has also a minor decay to the first excited 
state of 90Zirconium resulting in an emission of a positron with maximum energy 
of 1.78 MeV and mean energy of 0.7 MeV. When the kinetic energy of this 
positron has been transferred to surrounding material the positron annihilates 
with a nearby electron resulting in an emission of two photons each with the 
energy of 511 keV. These are emitted in opposite directions in order to conserve 
momentum. Since the distribution of the two photon pairs are isotropic, only a 
small number of these photons will be possible to detect with the PET camera 
detectors. When the photons are not attenuated along their path, they can be 
detected generating an event called a “true coincidence”. A coincidence is simply 
a simultaneous detection by two detectors within a time window sufficiently small 
in order to discriminate other photons not coming from the same annihilation 
process.  
The abundance of the beta plus decay from 90Y occurs only in about 32 cases out 
of one million [4].  
Because of its beta minus emission, 90Y is mainly used for radionuclide therapy, 
resulting in high energy electrons that can cause a therapeutical absorbed dose 
for a carcinoma tumour. The maximum and average energy for this electron is 
2.27 MeV and 0.9337 MeV, respectively [5]. The average path length is calculated 
to be 4.0 mm, for soft tissue using data from the National Institute of Standards 
and Technology (NIST) [6]. 
 
 
 
 
 
 
 
 
Figure 1. Decay scheme of the 90Y decay. Redrawn from reference [3]. 
 
In the Single Photon Emission Computed Tomography (SPECT) it is bremsstrahlung 
photons from the 90Y that are detected. This is possible since the electrons coming 
from the beta minus decay from 90Y interact with the strong coulomb field around 
an atomic nucleus which causes the electron to change its direction, thus causing 
7 
 
the emission of a bremsstrahlung photon. These photons are detected in the 
SPECT camera´s detector crystal. SPECT is the currently used imaging method 
after SIRT-treatment. To quantify the continuous bremsstrahlung spectrum with 
SPECT a lot of corrections are needed, since no clear photo peak exists within this 
beta spectrum. The photons coming from the 90Y bremsstrahlung production has 
an energy range up to 2.27 MeV which builds up the spectrum with wanted, but 
mostly unwanted photons in each energy channel. The correction methods 
necessary for quantification are many and the result is not easily gained. All 
methods are thoroughly described in the thesis of David Minarik [7] and will not 
be discussed further, except for a short summary in the “activity quantification” 
section below. 
Both the PET and the SPECT camera reconstruct images with ordered subset 
expectation maximization (OSEM). The basic of OSEM is as follows [7]: 
• An initial image guess is created, usually a flat matrix 
• The initial guess is then projected to sinograms 
• The measured projection is compared with the initial guess sinogram 
• The comparison creates an error sinogram, which is backprojected  
• The initial image is updated with the backprojected error image 
This process goes on until a satisfying image is reached, or when the difference 
between the measured and calculated projection sinogram is sufficiently small. 
2.1 Purpose 
The main purpose of this work is to evaluate the ability to accurately quantify 
activity uptake in vivo, which is in a patient, with a clinical PET system using both 
18Fluorine (18F) and 90Y. In order to establish the accuracy in quantification of 90Y, 
SIR-spheres labelled with 90Y were used. Tests were performed to evaluate the 
advantages and disadvantages using these two radio nuclides. 18F was selected as 
the reference radionuclide since it is the most widely used radionuclide. 
In order to be familiar with the system some of the common image quality tests of 
the PET-camera were performed. 
 Factors of great importance in the comparison between these two camera 
systems are; image contrast, spatial resolution, sensitivity and the ability to 
quantify activity. The latter is of great importance and also in focus of this thesis. 
The aim was thus to evaluate the activity quantification and compare the results 
from PET and SPECT measurements, with the purpose of finding which of the two 
methods is the most accurate in quantification and which is the best system in 
regards to practical use. 
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2.3 Introduction to the SIRT treatment 
Radio-embolization with microspheres attached with 90Y radionuclides is an 
increasingly used method for treating un-resectable liver carcinoma. The 
treatment has been used for about two years at the Skåne University Hospital in 
Lund and the overall application has been used for about ten years worldwide. 
 
There is a large difference in the blood supply when comparing normal liver tissue 
with tumours in the liver. Tumours with a diameter larger than 20 mm has its 
main blood supply originated mostly from the hepatic artery, while normal liver 
tissue has its blood supply maintained by the portal vein [8]. Therefore, the 
radioactive spheres are administered directly in the hepatic artery and not the 
portal vein for the purpose of sparing the normal tissue against unnecessary 
radiation and absorbed dose. The small microspheres become permanently 
trapped in the vascular tree that supplies the tumours with blood and thereby 
giving a high local absorbed dose to the tumour over a long period (determined by 
the physical half-life of the radionuclide).  
Prior to the 90Y SIRT-treatment the administration of 99mTecnetium labelled 
macroaggregated albumin (99mTc-MAA) is required. This is performed in order to 
create an individual activity administration plan for the patient with respect to the 
possibility of failure location for the SIR-spheres. The administration of 99mTc-MAA 
is performed in the same manner as the upcoming SIRT-treatment with SIR-
spheres. The 99mTc -MAA particles have a range in size between 10-100 µm [9] 
which is in the same order as the SIR-spheres. Within this pre-treatment 
operation, coiling against possible pathways for the microspheres is performed. 
This is in order to evaluate and quantify possible shunting of 90Y particles from the 
liver into the lungs, but also to determine the blood reflux to nearby endocrine 
organs [10]. The coiling procedure is then clinically verified with a 99mTc-MAA 
injection along with planar gamma camera imaging. The number of counts 
registered in a region of interest (ROI) over the right and the left lung are 
calculated and taken into consideration in the treatment plan. The result from this 
operation is taken into consideration for the upcoming treatment planning, which 
will be discussed more in “Absorbed dose determination”. 
 
After the infusion of the 90Y labelled spheres, a SPECT imaging is routinely 
performed, with the purpose of determining the distribution of the activity within 
the liver, from which there is a possibility to perform an absorbed dose map. 
Much work on the methods used for activity quantification with the SPECT-
camera has been performed in a PhD work by David Minarik, with the main 
purpose to quantify 90Y SPECT images. This work has led to the possibility of 
quantifying bremsstrahlung images from SPECT.  
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2.3.1 The characteristics of SIR-spheres 
The small spheres attached with 90Y are available in two different models as 
presented in table 1 below. Only the SIR-spheres are available in Lund at the 
moment.  
Table 1. Comparison properties of resin spheres and glass spheres [11]. 
Parameter Resin Glass 
Trade name SIR-Spheres TheraSpheres 
Manufacturer and 
location 
Sirtex Medical, Lane 
Cove, Australia 
MDS Nordion, Ottawa, 
Canada 
Diameter 20-60 µm 20-30 µm 
Activity per particle 50 Bq 2 500 Bq 
Number of microspheres  
per 3-GBq vial 
40-80 x 106 1.2 x 106 
Material Resin with bound 90Y Glass with 90Y in matrix 
2.3.2 Determination of administered activity 
The “Body surface area” (BSA) is a parameter that forms the base for the 
treatment planning method used at the Skåne University Hospital in Lund. BSA is 
calculated from the following equation [12]: 
 
𝐵𝑆𝐴 = 0.20247 ∙ ℎ𝑒𝑖𝑔ℎ𝑡 0.725 ∙ 𝑤𝑒𝑖𝑔ℎ𝑡0.425  (2) 
 
and where  BSA is in units of m2, height is in units of meter and weight is in units 
of kilograms. 
 
The following equation is used in order to determine the amount of 90Y activity 
that needs to be administered into the liver: 
 
𝐴𝐵𝑆𝐴 (𝐺𝐵𝑞) = 𝐵𝑆𝐴 − 0.2 + � 𝑡𝑢𝑚𝑜𝑢𝑟 𝑣𝑜𝑙𝑢𝑚𝑒𝑡𝑢𝑚𝑜𝑢𝑟 𝑣𝑜𝑙𝑢𝑚𝑒+𝑛𝑜𝑟𝑚𝑎𝑙 𝑙𝑖𝑣𝑒𝑟 𝑡𝑖𝑠𝑠𝑢𝑒 𝑣𝑜𝑙𝑢𝑚𝑒� (3) 
 
Activity reduction is performed after evaluating the planar 99mTc-MAA-images. 
Depending on the number of counts in a region of interest (ROI) over the lungs, 
relative to the counts on a ROI over the liver, the 90Y activity may be decreased by 
some factor kshunt. For example: if the shunting to the lungs is determined to be 
less than 10%, then all planned 90Y activity can be administered. If the shunting is 
larger than 20%, the SIRT treatment will not be completed. Values in between 
result in a reduction of the planned 90Y activity. 
 
Other factors that can decrease the activity to be administered are: 
• Small liver volume 
• Powerful pre-treatment chemotherapy 
• Large tumour involvement (> 65%) 
• Small tumour involvement (< 10%) 
• Cirrhosis patients (HCC)  
All of the factors above decrease the total administered activity by about 30%. 
The liver is anatomically divided into two lobes. If only the right lobe is treated the 
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reduction of activity is 1/3, since this approximately represents the volume given 
for the left liver lobe. The same procedure applies for the left lobe which is about 
1/3 of the total liver volume, which leads to an activity reduction of 2/3 [12]. 
 
2.4 Activity Quantification 
The evaluation of accurate activity quantification is one of the main purposes of 
this thesis. During the treatment in Lund, SPECT has been the post-treatment 
modality clinically applied to get an estimate of the activity distribution within the 
liver. From these images it is, of course, desirable to predict the outcome of the 
SIRT treatment by estimating the absorbed dose and relating the tumour 
response to the absorbed dose. This is, however, not done on a regular basis 
today. Possible adverse effects as well as tumour to normal liver absorbed dose 
could also be determined from these images [13]. The spatial resolution is 
generally better in PET than bremsstrahlung SPECT. Better spatial resolution is 
one of the main arguments why PET could be a good alternative to SPECT for 
post-treatment SIRT-patients. 
Much work has recently been performed regarding SPECT quantification with 90Y 
by David Minarik. Since the beta spectrum from a liver containing SIR-spheres is 
continuous and thus resulting in bremsstrahlung photons with energies from a 
wide range, the imaging and related activity quantification is not an easy task and 
is thoroughly discussed in his PhD thesis [7].  Figure 2 shows a spectrum from a 
phantom measurement with 90Y. The red arrows indicate the energy window used 
for activity quantification. 
A brief explanation of the activity quantification process used for SPECT is 
required. Initially, the CT image from the SPECT/CT study is scaled from HU to 
linear attenuation coefficients as a function of photon energies. After this a 
correction for scatter is performed using the effective source scatter estimation 
(ESSE) method. The measured image is convolved with a SIMIND produced 3D-
kernel representing scatter in the image and then weighted with the density map 
from the CT scan to compute the effective scatter source. After this the scatter 
component can be calculated by projecting the effective scatter source [7]. 
Basically, what is performed in the SPECT bremsstrahlung quantification is 
simulation of the spectra with Monte Carlo and then subtract what is scattered 
and unwanted within the specified energy window which is centred at 150 keV 
with an energy window of 60% [14].  
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Figure 2. The beta-spectrum produced from the 90Y microspheres within a phantom  
measurement during this thesis work. The red arrows indicate the energy window 
 used for activity measurement. 
 
The limitation of the PET system and related activity quantification are mostly due 
to physical phenomena, which show themselves as limiting factors of the spatial 
resolution. Some of these limitations are stated in the following section. 
 
1) The positrons travel an energy dependent distance with an average of 2.4 mm, 
in soft tissue, for positrons emitted from 18F and 4.0 mm for positrons emitted 
from 90Y. This limits the resolution of even the best camera on the market, which 
is about 5 mm, measured with 18F and performed according to the National 
Electrical Manufacturers association (NEMA) [15]. 
 
2) A limitation in the spatial resolution is the so called “Block effect” -also called 
the “depth of interaction”. This effect is a parameter coming from the attenuation 
probabilities lying in the nature of a photon travelling in a medium. A photon has 
a probability to pass through the initial crystal block and interacting with a crystal 
next to it. This leads to a misplacement in space and an offset line of response 
(LOR). This effect is more apparent with off centre annihilations, as visualized in 
Figure 3. Since the transaxial resolution according to the Discovery PET/CT 690 
datasheet [16] is 4.9 mm at 1 cm and 5.5 mm at 10 cm off centre, this effect is 
most likely small. This since more parameters than the “block effect” is included in 
this off centre decrease in spatial resolution.  
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Figure 3. The block effect visualized. The true event is the solid line, 
 which is detected as the dotted line, also called LOR. Image reference [17]. 
 
3) Non-collinearity is a degrading factor affecting the systems spatial resolution. It 
comes from the interacting process where the positron annihilates with an 
electron and they do not leave each other exactly “back to back” as expected, but 
instead with a deviation of approximately 0.25 degrees. This is because of residual 
momentum from the annihilation process [18]. This leads to misplacement 
dependent on the ring size, a larger ring gives a more pronounced effect. To 
calculate this deviation in millimeter the formula below can be used: 
𝑑𝑒𝑣𝑖𝑎𝑡𝑖𝑜𝑛 (𝑚𝑚) = 𝐷 ∙ 0.0022,   (4) 
 where D is the ring diameter in the units of millimeter. For an 81 cm detector ring 
this becomes 810x0.0022 = 1.78 mm. 
 
4) The pixel size is also a limiting factor. A larger matrix size means a smaller pixel 
size and also a theoretically better spatial resolution. The effect works the other 
way around on smaller matrix sizes. 
The detectors in the PET system also affect the spatial resolution. Some 
parameters are;  
• Detector width 
• Stopping power of the material 
• Sampling interval between the detectors 
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3 Material and methods 
3.1 The PET/CT camera used in this project 
The PET/CT-camera at the Skåne University Hospital in Lund that has been used in 
the project is a Discovery 690 (General Electric, Milwaukee, USA). Technical 
details about the PET/CT-system are presented in Table 2 below. 
 
Table 2. PET/CT camera information [15]. 
Transaxial Field of View with CT 
attenuation correction 70 cm 
Axial Field of View 15.7 cm 
Axial Sampling interval 3.27 mm 
Number of rings 24 
Number of image planes 47 
Coincidence window 4.9 ns 
Energy window 425-650 keV 
Number of Cerium activated Lutetium 
based crystals per ring 576 
Crystal size 4.2 mm x 6.3 mm x 25 mm 
Reconstruction time per frame 
(128x128 matrix) 150 s 
Number of CT slices 64 
Number of solid state elements for CT 58 368 
Rotational time Variable: 0.35 – 2 s 
CT reconstruction matrix 512 
 
3.1.1 Image Reconstruction 
Vue Point FXTM is the reconstruction software used in the PET camera system that 
incorporates information about “time-of-flight” (TOF) in the OSEM algorithm. TOF 
measures the Δt (s) between the incident annihilation photons and this 
information is used to create a smaller LOR than the whole FOV diameter. TOF 
information is dependent on the timing resolution of the PET system. The 
Discovery 690 has a timing resolution of 500 ps which gives a positioning 
uncertainty of 7.5 cm as determined by the equation: 
 
Δx  = c Δt / 2    (5) 
 
where Δt is the positioning uncertainty, Δx is the positioning error and c is the 
speed of light. 
 
The standard reconstruction protocol uses OSEM with 12 subsets and 3 iterations. 
The number of iterations and subsets can be increased or decreased post 
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measurement. The PET-data can also be acquired in list mode, which makes it 
possible to create other, but only shorter, acquisition times. 
 
3.1.2 Correction methods PET/CT 
The raw data which comes out from a measurement needs to be corrected from 
various physical effects. Necessary corrections for an accurate quantification of 
the PET-images are: scatter, random, dead-time and photon attenuation. The 
differences between these effects are described in Figure 4. 
 
True coincidence Random coincidence Scatter coincidence 
 
Figure 4. Different coincidences in PET imaging. The yellow star indicates a simulated radioactive 
source and the small dot in “scatter coincidence” indicates a scattered process. 
Redrawn from [19] page 192. 
 
Scatter correction: A model based scatter-algorithm is used [20]. Even though it is 
a rather complex procedure, an attempt to summarize this is performed. The 
scatter method is a step by step process: 
First a transmission information scan is obtained from the CT-scan. Then the PET- 
acquisition is performed. A normalization procedure is then applied on this PET-
acquisition making sure that all detectors remain equal regarding efficiency. Now 
attenuation correction is performed on the PET-acquisition. After this, scatter 
correction is performed using a scatter correction model. This model uses a fitting 
algorithm on the PET-acquisition data to estimate a scatter vector from a scatter 
tail. The PET-acquisition data is now compared with the scatter vector in order to 
identify the number of secondary emission data in the PET-acquisition data. At 
this time many estimated scatter vectors are calculated. The comparison leads to 
an estimation of secondary emission data. This is now corrected for on the 
original data, -that is- random coincidences are subtracted from the total prompt 
and only true coincidences are left [21]. 
 
Random correction: “Estimations of Singles” is the method used [22]. This means 
that the rate of random coincidences per second is estimated with the formula:  
 
𝑅𝑖,𝑗 = 2𝜏𝑆𝑎𝑆𝑏     (6) 
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where τ is the timing window of the PET system and Sa/Sb is the number of counts 
per second for each detector. Since Sa and Sb are approximately the same the 
equation simplifies to: 
 
𝑅𝑖,𝑗 = 2𝜏𝑆2     (7) 
 
This method assumes no redistribution of the activity [19]. In the case of SIRT 
treatment no redistribution and no leakage of the SIR-spheres is assumed once 
embolized in the tumour vessel [23]. Even if a redistribution of these SIR-spheres 
would occur, it would most likely not be possible to see on the images because it 
would probably be a slow process compared to the acquisition time. 
 
Attenuation correction: This is performed with the integrated CT in the Discovery 
690, which is a 64 slices GE LightspeedTM VCT1 with full 3D volumetric 
reconstruction. An image acquired with the CT creates the attenuation map to 
correct the PET images with. CT images are measured in Hounsfield Units (HU) 
which is converted to linear attenuation coefficients. The smaller voxel size in the 
CT images leads to the need of down sampling to a size matching the PET image 
matrix size. 
Dead time correction: to account for events that may have happened during the 
data handling of a recent coincidence event this correction is necessary. 
Depending of which radio nuclide is being measured the correction is more or less 
pronounced.  
Decay correction: A decay correction is automatically performed with the protocol 
chosen. For 90Y this is a minor problem since the measurement time in the PET or 
SPECT camera usually is small compared to the half-life of 90Y. 
Normalization: In order for all LOR to have the same response a correction is 
necessary for each detector pair. This correction matrix is a result of a 
measurement where the same result is expected for all LORs. This normalization 
correction is necessary since the sensitivity across the FOV has an almost pyramid 
shaped form, meaning the sensitivity of center decreases compared to the centre, 
which needs to be compensated for. The normalization for each detector pair is 
included in the OSEM reconstruction [15]. 
 
 
3.2 The SPECT/CT camera used in this project 
The SPECT camera with integrated CT is a General Electric Discovery VH. It consists 
of detection NaI(Tl)-crystals, which is 2.54 cm thick. When measuring 90Y activity a 
High Energy General Purpose (HEGP) collimator is chosen in order to minimize the 
septum penetration from the high energy photons coming from the 90Y 
bremsstrahlung spectrum. 
The energy window used for acquisition was a 60% energy window centred at 150 
                                                          
1 Volume CT Technology 
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keV. The energy window then extends from 105-195 keV. 
Number of slices for the SPECT camera is 64, and the matrix size is 64x64. This 
gives a voxel size of about 8x8x8 mm3. The SPECT acquisition was performed with 
60 s per angle and with 60 angles. 
The spatial resolution for the SPECT camera is about 16 mm, measured with 
131Iodine at 15 cm source to HEGP-collimator distance [7]. The sensitivity for the 
SPECT/CT system is 1.02 cps /MBq with the HEGP-collimator, measured with 90Y 
[7]. 
For attenuation correction purposes the integrated CT was used. The tube voltage 
was 140 kV and the anode current was 2.5 mAs. Matrix size for the CT images was 
128x128 which gave a voxel size of half the one for the SPECT images, which is 
4x4x4 mm3. 
 
 
3.2.1 Correction methods  
Since it is the bremsstrahlung spectrum that is measured, necessary corrections 
are performed to discriminate the scattered photons. The scattered photons 
contribution is simulated in computer software named SIMIND2. This program can 
Monte Carlo (MC) simulate the 90Y bremsstrahlung spectrum and thus give an 
indication of the amount of scattered photons present within the spectrum. After 
this a subtraction of the scattered photons is performed to obtain what is 
supposed to be the total number of unscattered photons. 
Attenuation correction was performed from the CT image where HU were 
converted to linear attenuation coefficients. 
Corrections and reconstructions were performed using the LundAdose3 software. 
Also a collimator-detector response correction was performed and included in the 
reconstruction process.  Six subsets and an optional number of iterations were 
used in the reconstruction algorithm. 
3.3 Experimental evaluation 
For the evaluation of the information from the PET and SPECT systems an image 
analysing program was necessary. For this the program AMIDE4 was chosen. 
AMIDE is a medical imaging data examiner that can import Dicom files and 
images, received from the PET and SPECT system. The program fits the needs for 
analysing the experimental outcome from these measurements very well. Mainly 
because of the ability to exactly determine the volume of interest (VOI), but  also 
because of the simplicity of applying it on images. 
 
                                                          
2 http://www2.msf.lu.se/simind/ 
3 http://www.exelisvis.com/network/usecase/detail.asp?l=French&app_id=148 
4 http://amide.sourceforge.net/ 
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18Fluorine Experiments  
In order to get a better understanding of the PET-system used at the clinical 
department at the Skåne University Hospital in Lund, some basic experiments 
were performed. Various performance tests of the PET system are necessary in 
order to evaluate the upcoming experimental results. 
The phantom used in most measurements was the NEMA body phantom, Figure 
5. 
 
 
Figure 5. The NEMA body phantom. The different sized spheres  
surrounding the simulated “lung” volume in the middle of the phantom. 
 
4 Quantification 18Fluorine 
A volume of interest (VOI) was created in AMIDE. This VOI was sphere-shaped and 
virtually placed to surround the spheres in the NEMA body phantom. Additionally 
8 mm in diameter was added to the true sphere-size for these VOIs.  
The mean activity was noted, and also the volume of the VOI. The total activity is 
the mean activity concentration multiplied with the volume of interest. 
Background subtraction was performed, even though it was very low.  
Noteworthy is that this is not a conventional method to quantify activity into a 
volume. But with the liver in mind, it is decided that this is an applicable method, 
concerning quantification. This since it is necessary to take into account the partial 
volume effect (PVE) which spreads out the activity into neighbouring voxels. This 
method would be more doubtful to apply when creating an absorbed dose map of 
the liver, since the absorbed dose surrounding the liver could be substantial. But 
one has to keep in mind that it is not the positrons that give rise to the large 
absorbed dose, it is the beta minus decay. Electrons from the beta minus decay 
have an average range of 4.0 mm compared to the average range of the positron, 
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which is 2.8 mm.  
Different number of iterations were compared and plotted. A table showing the 
relative background noise with increasing number of iterations from a VOI placed 
away from the hot spheres is shown, table 3. The 100% background noise level is 
determined from the 3 iteration value. 
 
4.1 Recovery Coefficients for 18Fluorine 
A Recovery Coefficient (RC) curve is said to test the PET system´s linear response 
with respect to different sized spheres when filled with radioactivity [24]. The 
NEMA body phantom (Figure 1) was used for this test. The RC curve describes the 
relative deviation from the true value of radioactivity; this is plotted as a function 
of sphere size. 
The ratio of the true activity and the measured activity was plotted. The 
measurements were evaluated using the AMIDE image processing software, 
where accurate sized VOIs can be applied. The VOIs were drawn on the CT -image 
and copied to the PET -image.  
The purpose was to compare the geometrical reconstructed activity with the true 
activity. VOI was made in accordance with the specified diameter for each sphere 
from the NEMA body phantom.  
Reconstructions with different numbers of iteration were also performed, since 
the clinical settings are 3 iterations and 12 subsets. Included is also a 
reconstruction without TOF. 
A line profile was drawn to compare and visualize the partial volume effect (PVE).  
Maximum values and 12.5% VOIs were also plotted with different number of 
iterations. The 12.5% VOI has a sphere shape with the volume equal to 1/8 of the 
original phantom sphere and chosen since it is an easy VOI to apply on images 
viewed at the workstation or anywhere else, thus easy to apply clinically. The 
12.5% VOI corresponds to a half diameter compared to a full size diameter VOI. 
Added were also the results from a 70% VOI, since it is also an accepted VOI 
according to The Netherlands protocol for standardisation and quantification of 
FDG whole body PET studies in multi-centre trials [25].  
The maximum value is included since it is simple to apply and proposed by 
Boellard et al [25]. 
 
4.2 Spheres to Background ratio 
Similar to the RC measurement described above, measurements with activity in 
the background and with different activity ratios relative to the spheres were 
performed. The theoretical and the quantified activity from the images were 
compared, with different number of iterations. AMIDE was used where VOIs of 
exact size of the spheres were applied and centred with help from the CT images. 
The size of the sphere-shaped VOIs to measure background activity were 7 mm in 
diameter, and the “lung” volume, which is the middle of the NEMA body phantom 
was used to evaluate the background noise level, and also for subtraction of this. 
This VOI was 7 mm in diameter as well.  
 
Activity ratios were 7:1, 5:1 and 3:1. The 7:1 ratio was chosen because a large 
contrast was desirable. The other ratios were chosen because of the assumption 
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in literature that the tumour to normal liver ratio often is said to be 3:1. The last 
5:1 ratio were chosen because it was in-between the other ratios.  
Recovery curves and curves showing the reconstructed ratios were performed. 
Also a summary graph showing standard protocol measurements with the 
different activity ratios are shown. Furthermore different sized VOIs applied in the 
non-background case, which is the RC measurement, are presented. 
A table presenting the true activity concentration in the background versus the 
spheres is shown below. 
 
Table 3. Theoretical activity concentrations from the 
 experiments with different activity ratios. 
 Spheres Background 
True activity 
ratio 
True activity conc. 
kBq/ml 
True activity conc. 
kBq/ml 
7:1 35.3 5.07 
5:1 26.7 5.30 
3:1 15.4 5.16 
 
5 Spatial resolution 18Fluorine and 90Yttrium 
A spatial resolution measurement was performed. Even though it was not made 
according to the NEMA protocol, which is the conventional performance 
measurement approach, it was  still applicable since only a relative comparison 
between 18F and 90Y was desired. Two line-sources, with different diameter, were 
filled with 18F activity, approximately 100 MBq each. They were placed on a plastic 
plate, both about 5 cm off axis on each side laterally viewed. On top of them an 
additional plastic plate was placed to ensure that the positrons emitted from 18F 
have something to interact with. Figure 6 shows the experimental setup. 
 
 
 
Figure 6. The experimental setup for the spatial resolution measurement with 18F. 
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The line sources´ inner diameter was about 1.4 mm for the thick line and the thin 
line source were about half that in size, which is 0.7 mm. The measurement was 
evaluated in AMIDE where a line profile could be applied and the tangential 
FWHM were obtained. 
 
The medical physicist employed at the clinical department had recently 
performed a similar measurement, but with 90Y instead of 18F. These 
measurements were available for this project and thus could be analysed in the 
same manner as for 18F. Matrix sizes 192x192 and 256x256 were compared and 
evaluated.  
6 Beta spectrum from 32Phosporus 
A simple test to see whether there is any visible differences when reconstructing 
images with different protocols was made. This was supplemented with the aim 
to find out whether or not the PET-camera finds any true coincidences from 32P, 
which is thought to be a pure beta minus emitter. 32P has a very small branch of 
positrons as well as 90Y. For 32P the positron branch is approximately 0.7 per GBq 
[26], thus there is a theoretical possibility to find a true coincidence. The purpose 
of the measurement was also to see if the camera mistakenly adds some counts 
originating from the bremsstrahlung spectra produced by the beta particles, and if 
these are detected as a true coincidence. The activity source used was about 40 
MBq of 32P. This is a rather low activity to statistically be able to find any true 
coincidences, but the activity concentration is perhaps sufficient to determine if 
any bremsstrahlung photons will be detected as annihilation photons. This since 
the amount of 32P was approximately one tablespoon (15 ml) and no further 
dilution was performed, this equals an activity concentration of about 3MBq/ml.  
Protocols used for the measurement were 18F and 90Y, since no protocol existed 
for 32P. 
A plastic sphere was filled with the 32P activity and then placed at the bottom of a 
larger phantom. This phantom was filled with water and a PET/CT scan was 
performed. The acquisition time was 20 minutes.  
A quick evaluation was performed and this lead to the need for background 
measurements. 
6.1 Background level 
As a follow up from the measurement with 32P above, another measurement was 
performed. To find out if there is any difference between the protocols used; 30 
min scans without any phantom (blank scan) with 18F and 90Y protocol were 
performed. A large VOI was created in AMIDE (200x150x150) and the total activity 
within this VOI was evaluated. The suspicion is that the background noise level is 
increased in the 90Y protocol and thus larger than in the 18F protocol, which could 
possibly be due to the large scale factor because of the small branch of positron 
decay for 90Y. The background noise level could perhaps determine if the 
difference in protocols used is a factor of about 30 200, similar to the positron 
branch ratio between 18F and 90Y. 
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7 90Yttrium simulation 
Since there was a shortage of 90Y in a major part of the spring, 18F was considered 
a substitute. The only obstacle was to get the activity representable to the 
expected number of coincidence photons from 90Y. This since the branch of 
positrons in 18F is about 30 200 times larger than for 90Y.  
In order to evaluate the results in a more quantitative manner it was necessary to 
reach a realistic activity level. A theoretical assumption was required; an 
assumption of a liver mass of 1.5 kg and density approximately equal to water 
gives a volume of 1.5 l. Assuming also an administration of 1.5 GBq, this gives a 
theoretical number of positrons per seconds of about 32 000 per litre, or in 
activity concentration 32 Bq/ml, for 18F. 
A large activity concentration was left in the NEMA body phantom day 1. The next 
day, a measurement with protocols for 18F and 90Y was performed separately. The 
activity concentration of 18F was then very low and calculated to be approximately 
30 Bq/ml. 
The PET camera makes a correction for the decay in the 18F protocol, but, of 
course, not the same in the 90Y protocol when measuring 18F. This had to be 
corrected for, manually with the following calculation. 
The time integral from 0 to 20 minutes (PET acquisition time) was calculated, that 
is; 
� exp�− ln(2)109.8 𝑡� 𝑑𝑡 = 18.79200  
                  (8) 
 
This shows that the decay not taken into account for is equal to the quotient 
18.79
20
= 0.94, which is a 6% decay during the 20 min measurement. The measured 
values, from the 90Y protocol, were therefore divided by 0.94. The low correction 
factor already performed from the systems 90Y protocol were 1.00815, which was 
ignored. 
A simulated 90Y activity was calculated from the results from the 90Y protocol 
measurement. The factor 967000
32
 was multiplied with the true 18F activity. This 
activity ratio is plotted and the same method is applied on the 18F measurement. 
 
90Yttrium experiments 
8 Recovery coefficient 90Yttrium 
Measurements with the NEMA body phantom had recently been performed by 
the physicists at the clinical department at SUS in Lund. About 300 MBq 90Y had 
been put into the NEMA body phantoms spheres. 
A 30 minute PET and SPECT -scan was performed and compared with respect to 
quantitative results.   
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Measurements with the phantom were performed over a few weeks, which 
means that the same phantom measurement but with different activities due to 
decay were scanned. This was performed until almost no activity was left in the 
phantom. The results are presented as different activity concentrations and the 
evaluation is performed in AMIDE with sphere sized VOIs. These VOIs were 
centred using the CT image. Low contrast between the plastic spheres in the 
NEMA body phantom and the surrounding media prevented a full size VOI from 
the SPECT measurement to be centred, which lead to the use of a smaller VOI, 
70% of true volume size. This 70%-VOI size was used for evaluation and the results 
were used when comparing the PET to the SPECT images.  
With the PET-camera system it is optional to choose a shorter acquisition time 
from a specific measurement. This was performed in order to find out if a shorter 
acquisition time than 30 min for SIRT-treated patients is possible, considering the 
low positron branch and also the low statistics. The patient can, of course, not 
spend too much time in the PET-camera. The first of the total four 30 min scans 
was reconstructed with shorter acquisition times, that is: 20, 10, 5, 2 and 1 
minute. Even though 1 minute is less likely to give a good image the PET-cameras 
possible limitations could be interesting. 
 
8.1 Quantification of 90Yttrium 
For this evaluation, a 9 mm in diameter larger VOI than the true spheres were 
applied both on the PET and SPECT measurements as used in “recovery coefficient 
90Y” above.  
Results were analysed with different number of iterations. As previously stated; 
larger VOIs than the spheres is not a conventional method of quantifying activity 
concentration, but perhaps still applicable, since only a relative result is required 
in order to compare PET-camera with the SPECT-camera measurements. 
9 Patient evaluation 1 
Last fall a double post-SIRT measurement was performed. The patient received an 
administered activity of 1230 MBq 90Y. The method for quantification was 
threshold based segmentation performed in AMIDE. The threshold for the PET-
measurements was 100 kBq/ml and 50 kBq/voxel for the SPECT measurement, 
due to the double voxel size in the SPECT images. PET-images were reconstructed 
with 3 iterations and 12 subsets. Since the data had disappeared from the hard 
drive no additional reconstructions could be performed. SPECT images were 
reconstructed with 50 iterations and 12 subsets. 
 
9.1 Patient evaluation 2 
The patient for SIRT-treatment in May was administered 1030 MBq into the liver. 
The patient was measured both in the PET-camera and the SPECT-camera. Once 
again segmentation based threshold was the evaluation method used in AMIDE. A 
larger number of iterations could be performed since the measurement had not 
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been deleted from the hard drive as was the case with the first patient measured 
in the PET camera.  
9.2 Patient evaluation 3 
A third and also a fourth patient were SIRT-treated in June. The third patient 
received 790 MBq into the liver. Patient three was measured in both PET- and 
SPECT camera for comparison. Segmentation based threshold was used for the 
quantification evaluation. Patient four did not complete both measurements, thus 
no results are presented. 
 
10 and 10.1  
Simulated “liver” with 90Yttrium  
Due to gravity and segmentation problems with the SIR-spheres, a solution based 
on gelatin was used. This was mixed up in a theoretical “liver” volume of 1.5 litres. 
This “liver” was scanned both in the PET and the SPECT camera. 90Y activity 
inserted in the “liver” volume was about 800 MBq. 
Later on, small plastic vials with different amount of activity were inserted into 
this “liver” volume. The simulated “liver” was put into an empty phantom which 
was filled up with water. This water phantom was about 10.7 litres in total and 
elliptical to simulate a patient torso. PET and SPECT scans were performed in an 
upright position; otherwise the “liver” volume could move during scan. Figure 7 
shows the finished phantom. 
 
Figure 7. Simulated “liver” volume in water phantom before entering the PET-camera. 
In total the activity was about 1000 MBq of 90Y. However, this is a rather uncertain 
number due to some problems when creating the phantom. First the spoon which 
was used for stirring became contaminated and thus contained some unknown 90Y 
activity. A rough and generous estimation is that the spoon contained 2% of the 
total activity.  
The plastic vials were measured, but in a wrong geometry for the calibration 
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settings of the ion-chamber. A 20% error was set to this measurement. To these 
errors the ion-chamber calibration error is added, which is 5%. In total the error 
bars became 10%. 
Much effort was given to analyse the results from the PET and SPECT 
measurements. Threshold based segmentation was applied in AMIDE. Corrections 
for the fact that the SPECT values are given in MBq/voxel and the PET values are 
given in Bq/ml had to be performed. The threshold for the SPECT-images then 
became 50 k Bq/voxel and for the PET-images it became 100 kBq/ml, since one 
SPECT voxel was about 0.5 ml. 
 
When measuring the “liver” volume without surrounding water only one Bed-
position was required to cover the volume. With the water phantom around, two 
Bed-positions were required. A longer acquisition measurement of 60 min per 
Bed-position with the PET-camera was also performed on this setup. 
  
The SPECT measurements were performed with 60 angles each of 60 seconds 
acquisition time. For attenuation correction the CT-scan was used. SPECT images 
were reconstructed in LundAdose which uses the OSEM algorithm with 12 subsets 
and with an optional number of iterations. 
 
10.3 Simulated “liver” with 90Yttrium  
Since a second opportunity appeared to create phantoms with 90Y, because of 
leftovers from SIRT-patients, an easier and more accurate experimental strategy 
was invented.  
The same “liver” volume as used in previous experiments was used. This time no 
hot vials were produced, and the aim was simply a homogenous activity 
distribution. Gelatin was used again, but the 90Y activity was inserted earlier than 
previous experiment. The stirring spoon was replaced with a condom covered 
glass rod, to avoid contaminating the material. When the gelatin was stiff enough 
the protecting condom was detached from the glass rod. No spill from the 
measured 90Y activity could be noticed. Inserted into the “liver” volume was 1550 
MBq of 90Y which was then placed at the bottom of the same water phantom as 
used previously (Figure 7). Measurements were performed both in the PET- and 
SPECT-camera.  
To test the possible Bed-overlap issue, different settings with the overlap were 
performed. It consisted of one normal scan, one with the largest possible overlap 
and one with minimal possible overlap. Comparisons between these different 
measurements were analysed. 
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10.4 Bed overlap with simulated 90Yttrium 
Since the previous patient measurement showed a string of additional activity 
across the Bed-overlap this measurement was performed. In this experiment 18F 
became a substitute because no 90Y was available at SUS in Lund. 
The “liver” volume was filled with about 200 MBq 18F. Next day PET-
measurements were performed. One respective two Bed positions were 
performed for the setup. 90Y protocol was used for all measurements. The 18F 
activity was multiplied with a factor of 30 220 in the calculations, to simulate the   
positron branch from 90Y. Decay correction was performed as described in 
equation (8).  
The ambition was to see different quantification results depending on how many 
Bed positions used in the measurements. 
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Results and discussion 
4 Activity Quantification of 18Fluorine 
 
 
Figure 8. Total activity within a large VOI as a function of sphere size.  
Also is shown the different number of iterations. 
 
 
Table 4. Relative background noise level with different number of iterations. 
# Iterations Relative background 
noise 
3 100% 
20 156% 
30 158% 
 
As can be seen from Figure 8 the PET-system recovers the theoretical activity 
within an accuracy of 94% in average. Since the defined VOIs are larger as 
compared to the actual volume of the sphere it is expected that almost all counts 
will be included within this VOI. A disadvantage of using large VOI is that counts 
from external activity, such as activity within the pipe, will be included in the 
activity calculation. Also minor deviations in sizes between the different spheres 
may be due to small water drips left in the spheres before the activity was 
injected. Furthermore, small air bubbles can influence the activity quantification. 
This would have a larger effect on the smaller spheres than the bigger spheres, 
relatively seen, this can also be suspected from the diagram.  
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There is no significant improvement when using an increased number of 
iterations.  The background noise is affected though, as can be seen in Table 4 
which is expected as the iterations increase. 
 
 
4.1 and 4.2 
Recovery Coefficients and different background ratios with 
18Fluorine 
 
There is a significant difference between small and large spheres when comparing 
the activity concentration obtained from reconstructed images with the known 
objects activity concentration. This is generally termed the partial volume effect 
(PVE) [27, 28]. Since the spatial resolution for PET cameras is limited, due to the 
parameters discussed in the theory section, the result cannot be expected to be 
100%. 
A correction of the results is therefore necessary to compensate for the PVE 
effect. One approach of such correction is to apply the recovery coefficients (RC) 
which is an easy implementation. In clinical application this probably may not be 
accurate since some types of cancer tumours do not have spherical shapes. 
Nevertheless, the PVE is an important fact to keep in mind when the aim is to 
quantify SUV values within small tumours. As a rule of thumb the approximate 
object size required for an accurate reconstruction of the activity concentration is 
approximately 2-3 times FWHM, without loss of linearity, which seems to match 
the results [29].  
 
From Figure 9 and 10, it is shown that there is a difference in the results when 
increasing the number of iterations. It seems like a better result is reached with an 
increased number of iterations. Only a small change in the result is noted when 
comparing 20 and 30 iterations. An increased number of iterations for the 
purpose of activity quantifying could be applied post-acquisition and thus would 
not affect the patient flow through the clinic. The result implies that for the best 
separation of different levels of activity, at least 20 iterations are required. This is 
useful if a calculation of the absorbed dose would be performed. The result when 
not using the TOF seems to be accurate, as can be seen in Figure 11. However, 
this graph is maybe somewhat misleading since it only shows the activity ratio, 
which seems good for non-TOF. The results are best presented in Figure 10. 
The sphere- to- background ratio also affects the result due to the “spill-in” and 
“spill-out” of counts which has a more pronounced effect when the activity 
quotient is larger. A background activity closer to the spheres´ activity makes the 
spheres´ recovery look better due to the fact that the spill-in exceeds the spill-out 
effect.  
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Figure 9. Recovery coefficient for the measurements with the NEMA body phantom with sphere 
sized VOIs. The graph also shows the different number of iterations as well as without TOF. 
0
0.2
0.4
0.6
0.8
1
0 10 20 30 40
Ra
tio
: M
ea
su
re
d/
Tr
ue
 a
ct
iv
ity
 
Sphere diameter (mm) 
Recovery Coefficient 18F 
1 it
 3 it
7 it
10 it
20 it
30 it
3it non TOF
29 
 
 
Figure 10. The activity ratios as a function of sphere diameter and with different number of 
iterations. Results also includes without TOF. 
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Figure 11. Activity ratios from the measurements performed, shown with different number of 
iterations and without TOF. 
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Regarding the Recovery comparison plot, Figure 12, there are significant 
differences worth noting. The 70% VOI has the best match out of these since a 
smaller VOI excludes many of the voxels affected by the PVE, which is the spill-
out. An even better result is reached with the smaller 12.5%-VOI. For this VOI-size 
the only large deviation is the smallest sphere (10 mm in diameter). Maximum 
values do not match the line profiles in Figure 13. This is probably because of that 
the line profile drawn did not pass through the maximum pixel value.  
 
 
 
 
Figure 12. Recovery coefficient comparison for the standard protocol, that is with 
 12 subsets and 3 iterations. Here presented with and without background activity complemented 
with max value, 70% and, 12.5% VOI without background activity. 
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The line profiles plotted in Figure 13 shows that the maximum value is rather 
constant for spheres larger than approximately 2.4 times FWHM. The two 
smallest spheres do not have as large maximum values as the others due to the 
PVE, as illustrated by Soret et. al in the figure below, figure 14 [27].  
 
 
 
Figure 13. Line profiles with intensity as a function of distance and with different sphere sizes. 
 
 
 
 
Figure 14. The partial volume effect illustrated [27]. 
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5 Spatial resolution 
 
Table 5. Results from the spatial resolution measurement with 18F and 90Y. 
18F 192x192 matrix Thick line Thin line 
FWHM 8.1 mm 6.5 mm 
18F 256x256 matrix   
FWHM 7.3 mm 6.2 mm 
 
   
90Y 192x192 matrix 
FWHM 7.1 mm 5.9 mm 
90Y 256x256 matrix   
FWHM 6.7 mm 7.0 mm 
 
The spatial resolution results, shown in table 5 were not as accurate as expected. 
This might be due to the fact that the NEMA protocol was not used. The numerical 
values would probably be in better agreement if a correct measurement, 
according to the NEMA protocol, is performed. Measurement according to the 
NEMA standard was conducted during the acceptance tests of the PET system and 
showed satisfactory results. The differences between the NEMA standard test and 
the measurement performed in this experiment is that filtered back projection is 
the standard reconstruction method regarding the NEMA protocol and OSEM is 
the reconstruction method used in this experiment. Also there is a difference in 
post-filtration of the image. In the NEMA standard there is no post-filtration 
performed as there is on a clinical PET measurement [30].  
An additional reason for the numerical value being larger than expected may be 
the possibility for the positrons to interact in the plastic compartments above and 
beneath the line source. This can produce a wider FWHM compared to a small 
point source surrounded with air, as in a NEMA standard measurement. Also 
noteworthy is that a thinner line source results in a smaller FWHM for 18F but not 
for the larger matrix size and 90Y. Since the values are small and the line profile 
performed in AMIDE is arbitrarily set, the result may vary because of this. 
 
According to the manufacturers data, the spatial resolution should be 4.9 mm at a 
distance of 1 cm from the centre [16]. If a linear relationship in the transaxial 
direction could be assumed for the FWHM this would give a value of 5.2 mm for 
the FWHM at a distance of 5 cm off-axis. 
When using a larger image matrix size the value for the FWHM was improved for 
18F but degraded for 90Y. One possible explanation is that a lower statistical 
readout per voxel gives a wider Gaussian for the 256x256 matrix as compared to 
the 192x192 matrix. 
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6 Beta spectrum from 32Phosporus 
 
 
Figure 15. To the left a measurement with a sphere containing 32P and using the 18F acquisition 
protocol is shown. To the right the same phantom setup but now acquired with the 90Y protocol is 
shown. Images were evaluated at the workstation connected to the PET system. 
As can be seen in Figure 15, there is a significant difference regarding the 
measured activity. With the 90Y protocol there is an activity in the image, in 
contrast to the F-18 protocol where no activity is measured. 
This result seems to be dependent of which protocol used. Since only about 32 
ppm positrons can be expected from 90Y, as compared to 96.7% for 18F there is a 
large difference in how the overall counts are being scaled dependent on the 
protocol being used. The hotspots in the PET image can probably be referred to 
background noise which is multiplied with a factor k. 
 
 𝑘 =  0,967
32∗10^−6 ≈  30 220    (9) 
That gives rise to the apparent ‘activity’ in the image. One potential source of 
additional counts appearing in a voxel may be the low activity in the LYSO crystals 
itself. According to Bettinardi et al [22] this natural activity in the crystal material 
would contribute the count rate with about 1 cps, thus this should not produce a 
significant contribution. However, when scaling with the factor k of about 30 000 
this becomes somewhat greater and perhaps significant. Another possible 
explanation to these hotspots is the multiplicative factor combined with an 
incorrectly calibrated detector-pair. An inaccurate normalization of the detector-
pairs can lead to an increased image noise [19]. 
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The PET camera does not mistakenly refer any bremsstrahlung photons from the 
32P sphere to be a true coincidence, and the branch of positrons from 32P is most 
likely too low to be detectable, at least with this low activity. If a larger activity 
would be used, maybe it would be possible to get an image as well. The activity 
required would be very large though. 
 
6.1 Background level 
 
 
Figure 16. Image showing the blank scan measurement and the VOI in one plane. 
 
Table 6. Background level measurement. 
 
 
 
 
As seen in Table 6 there is a clear relationship between the background noise level 
and the theoretical assumption of a matrix multiplication. As assumed the 
difference is a factor of about 30 000. 
Protocol 
Mean 
value 
(Bq/ml) 
Measured 
Quotient 
Theoretical 
Quotient 
18F 0.05   
90Y 1563 30842 30220 
    
36 
 
If the background value is multiplied with the volume the total activity is 
determined. This shows that approximately 1 MBq exist in the image from the 90Y 
protocol. Even though there is zero activity in the 18F measurement. 
A possible source for this background level is the low content of 176Lutetium in the 
LYSO crystals within the PET´s detector rings. These unwanted extra counts would 
need to be corrected for, in order to make an accurate activity quantification, as 
suggested by Gates et al [13]. 
 
7 90Yttrium simulation 
 
Figure 17. Graph showing the activity ratio, and comparing the 90Y protocol with the 18F protocol. 
 
A large difference between the different protocols used is seen in Figure 17 for 
the smaller spheres. This is most likely not because of the more accurate 
measurement with the 90Y protocol but because of the influence of background 
noise. The absolute values are better for the larger spheres in this measurement 
than for the RC curve. This is most likely due to background noise as well. A small 
number of counts are more affected by a background noise than a large number 
of counts, relatively seen.  
0
0.2
0.4
0.6
0.8
1
0 10 20 30 40
Ra
tio
: m
ea
su
re
d/
tr
ue
 a
ct
iv
ity
 
Sphere diamter (mm) 
90Y simulation 
3 it Y-90 prot.
20 it Y-90 prot.
3 it F-18 prot.
20 it F-18 prot.
37 
 
8 Recovery coefficient 90Yttrium 
 
 
Figure 18. Recovery coefficient measured with Y-90 in the PET-camera. The curves present different 
activity concentrations with the RC-curve as a function of sphere diameter. Sphere sized VOI was 
used for all these measurements. 
 
 
Figure 19. Comparison of RC curve between PET and SPECT measurement.  
Also included is the non-TOF reconstruction. 
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Figure 20. Recovery curves with different acquisition times. 
 
The recovery curve for 90Y, in Figure 18, is very similar to the RC-curve performed 
with 18F, Figure 9. The relative value is higher though, which is most pronounced 
for the larger spheres. This might be because of more background noise in the 
image as discussed before. 
Interesting is that with the lowest activity concentration the curve becomes very 
deviant. It seems as if there exists a least required activity concentration 
necessary for the PET-camera. Also it seems like a nonlinear relationship with 
respect to spheres size is apparent. The smaller spheres´ recovery is much worse 
than the larger ones. Noteworthy is that there is a large eight time difference 
between the two lowest activity concentrations. Values in between is expected. 
 
Regarding the comparison between the PET and SPECT camera measurements in 
Figure 19, it seems like the PET-camera system has a more consistent behaviour. 
Except for the non-TOF reconstruction results, which are worse than with TOF. No 
point of the curve is better with the SPECT-system than the PET-system. The only 
spheres that come somewhat near the PET result are the largest and the second 
smallest. Unfortunately for the SPECT-system this behaviour does not seem linear 
with sphere size. 
When comparing different acquisition times as in Figure 20, there is a large 
difference between the curves. Even though an acquisition time of 1 or 2 minutes 
is not of relevance, it is of interest to see the behaviour of the quantification 
results with short acquisition times. At least a 10 minute scan seems necessary for 
a stable result. 
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8.1 Quantification 90Yttrium 
 
 
Figure 21. Comparison of the total activity measurement with PET and SPECT camera. 
 A VOI larger than the actual sphere are applied and evaluated. 
 
Figure 21 shows the result from the SPECT and PET measurement.  
It can be seen that there once again is a difference between 6 and 50 iterations 
for the SPECT measurements. Fifty iterations seem to give a better result than 6 
iterations. An unexplained decrease is seen between the 13 and 37 mm sphere. A 
possible reason would be inhomogeneous activity concentration. However, the 
PET curves are not showing any sign of an inhomogeneous activity concentration. 
Perhaps something in the reconstruction algorithm performed at the SPECT 
images could be the explanation.  
 
The PET curves do not show any improvement when performing more iterations. 
To keep in mind is that these measurements are performed with an activity 
concentration of about 6.5 MBq/ml, which implies good statistics. 
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9 Patient evaluation 1 
 
Table 7. Results from patient 1. 
Patient 1 Measured activity (MBq) 
True activity 
(MBq) Deviation 
PET 20 min per BED (3 it) 1233 1018±72 +19% 
SPECT 30 min (50 it) 1009 1007±71  +0.1% 
 
The results provided in Table 7, show that the PET-camera overestimate the 
activity with about 20% as compared to the results obtained with SPECT which is 
good agreement for the activity quantification.  
 
The error in the measurement of the true activity is estimated to 7%, where 5% 
relates to uncertainty in the ion-chamber calibration and the additional 2% from 
the geometric uncertainties when measuring the catheters, needles and 
containers after the SIRT-treatment. 
 
The SPECT camera is well within these error bars but the PET-camera 
overestimates the total activity with 19% and thus is beyond these error bars. 
Even though these values could be refined with other thresholds (larger) this was 
not performed. The reason is because it is desired to cover up the whole  liver 
with the segmentation. With a larger segmentation to many voxels which contains 
activity is excluded and thus gives a closer match to the total activity aimed for, 
since the total activity is overestimated. This would of course not show the 
accurate result. Perhaps a larger threshold could be used if a least activity is 
decided for absorbed dose calculation. 
 
The overestimation for the PET-system is interesting. One possible reason, again, 
is the additional counts from the LYSO-crystals, which has not been corrected for 
in the activity quantification. This since no good method could be figured out to 
apply on such subtraction. However, such a subtraction must be performed 
before computer system creates the tomographic images. Since the PET -camera 
is considered a black box when it comes to performing changes on calculation 
steps this would not be possible within this project.  
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Figure 22. To the left the PET-image from patient evaluation 1. To the right the SPECT-image  
from the same patient. 
 
 
Figure 23.PET-images from patient 1 showing the segmentation applied in 
 coronal and transversal direction. 
 
 
Figure 24. SPECT-images from patient 1 showing the segmentation applied in 
 coronal and transversal direction. 
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9.1 Patient evaluation 2 
 
Table 8. Results from patient evaluation 2. 
Patient 2 Measured activity (MBq) 
True activity 
(MBq) Deviation 
PET 20 min per Bed (3 it) 964 821±58 +19.4% 
PET 20 min per Bed (20 it) 1013 821±58  +23.4% 
SPECT 30 min (50 it) 725 812±57 -10.7% 
 
Also in this evaluation the activity concentration from the noisy PET-image shows 
an overestimation of total activity as presented in Table 8. The result is about the 
same as the first patient evaluation. An underestimation from the SPECT-
measurement is also seen for this patient. A better result could also be obtained if 
a smaller threshold were applied. But if a smaller value of the threshold were 
applied in the SPECT-images a smaller threshold would thus be necessary in the 
PET-images in order to keep the ratio about 2 because of the ml per voxel 
relationship. This would give a larger overestimation in the PET-images and also 
add more background noise in the total activity quantification. A perfect threshold 
for segmentation purposes is difficult to determine. 
 
Surprisingly when looking at the maximum intensity projection (MIP) -image at 
the PET workstation a possible Bed-overlap problem is apparent. This is visualized 
in Figure 25. From this Figure 25 it seems like the field of view overlap causes 
extra counts in the image. A possible explanation for this is the nonlinear 
sensitivity over the axial FOV. This is corrected for with a matrix to give an equal 
sensitivity along the FOV. This in combination with additional counts from the 
LYSO crystal elements could potentially increase the quantification result. 
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Figure 25. Possible Bed overlap problem shown. Maximum intensity projection (MIP) 
image from the PET workstation. 
 
Image 26 and 27 compares 3 and 20 iterations, and shows that the hotspots 
seems more smeared out in the 3 iteration image. With 20 iterations the hotspots 
has a more homogenous distribution than with 3 iterations. Though, the voxels, 
and hence the absorbed dose, will be more affected by 20 iterations since the 
hotspots intensity is more pronounced.  Perhaps a smoother distribution of the 
background noise is preferred if it cannot be subtracted. In addition the 
quantitative result does not become better with 20 iterations, but instead 
worsened by 4%. One should keep in mind that this is partly due to the threshold 
based segmentation evaluation method, which seems to add some of the 
hotspots surrounding the liver. Even though the 20 iteration image seems to have 
a more accurate activity distribution, there is a significant contribution to the total 
quantitative result from the hotspots surrounding the liver. Some of them could 
perhaps be accounted for because of respiratory motions during acquisition but 
some of them are most likely not supposed to contribute to the total activity. A 
more precise segmentation method is to prefer. 
 
 
Figure 26. Three iterations PET-image of patient 2 to the left and 20 iterations to the right. 
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Figure 27. Images from AMIDE shows the threshold based segmentation VOIs applied on PET-images 
from patient 2. Three iterations to the right and 20 iterations to the left. 
 
 
 
10 Simulated “liver” with 90Yttrium  
 
The results from this measurement were somewhat surprising, as presented in 
table 9. The SPECT camera has a minor deviation of about 2% whereas PET-
camera underestimates the total activity with 18%. A low activity concentration is 
underestimated with the PET-camera as seen in Figure 18. This might affect the 
total quantification. Although the activity concentration in the “liver” volume 
would be at least: 
 
800 𝑀𝐵𝑞
1300 𝑚𝑙 ≈ 0.6 𝑀𝐵𝑞/𝑚𝑙    (10) 
The volume 1300 ml comes from the fact that it is impossible to fill the “liver” 
volume with gelatin, since a stirring was necessary and thus could lead to 
unwanted spill. Ultra sound gel was put on top of the “liver” volume to fill up the 
volume, after the vials were inserted.  
The gelatine mixture with SIR-spheres did not become very homogenously 
distributed as seen in figure 29. This is probably because of the gelatin had 
becoming too stiff before the 90Y microspheres were inserted.  
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Figure 28. PET-quantification results from the “liver” volume alone.  
Total activity as a function of iterations is shown. 
 
 
 
Figure 29. PET-image to the left showing the activity distribution in the “liver” volume, a similar 
image but with the SPECT-camera is shown to the right. The images do not show the same slice. 
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Figure 30. SPECT-quantification results from the “liver” volume alone. 
 Total activity as a function of iterations is shown. 
 
Table 9. The absolute values from the measurement with the “liver” volume. The 
PET value is from 3 iterations and the SPECT value is from 6 iterations. 
"Liver" volume Measured activity (MBq) True activity (MBq) Deviation 
PET 663 811±57 -18.3% 
SPECT 841 821±58 +2.4% 
 
 
10.1 Simulated “liver” with 90Yttrium 
 
 
Figure 31. PET-quantification results with the “liver” volume in the water phantom. 
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Figure 32. SPECT-quantification results with the “liver” volume in the water phantom. 
 
Table 10. Results from the “liver” volume in water phantom measurement. 
"Liver" volume in 
water phantom 
Measured activity 
(MBq) 
True activity 
(MBq) Deviation 
PET 30 min  
PET 60 min 
1025 
903 
993±70  
966±68 
 
+3.2% 
-6.5% 
 
SPECT 30 min 1134 983±69 +15.4% 
 
The PET-camera shows a deviation of about 3% when quantifying the 90Y content, 
as seen in Table 10. The SPECT-camera shows an overestimation of about 15%. 
One possible explanation to this is that the vials inserted in the “liver” volume 
contain more activity than expected. About 20% increase for both measurements 
indicates this. 
 
The scan with 60 minutes per Bed -position shows a deviation from the 30 
minutes scan of 6.5 %. A longer acquisition time should give better statistics and 
thus improve the quantitative result. This was not the case this time, even though 
the 10% error estimation is fulfilled. Thoughts of why the quantification result 
decreases with better statistics were awoken. A possible explanation is that the 
longer acquisition scan is the most accurate and that the small amount of 
overestimation is reduced with better statistics. 
The only thing certain is that the PET and the SPECT camera show different results 
when quantifying 90Y. 
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10.4 Bed overlap with simulated 90Yttrium 
 
Table 11. Different number of Bed positions with 90Y  
simulation in the “liver” volume. 
PET 20 min per Bed Measured Theoretical*  
# Beds  activity  (MBq) activity (MBq) Deviation 
1 2128 2201 -3.3% 
2 1782 1844 -3.4% 
1 847 876 -3.3% 
2 715 748 -4.4% 
1 494 502 -1.7% 
2 409 426 -4.0% 
*18F converted to 90Y activity 
The results in Table 11 show no overestimation in activity for the measurements. 
Interesting is that the quantitative results are very close to the true activity. A 
source of error in this measurement is the fact that the water phantom 
surrounding the “liver” volume was not used; hence errors from the attenuation 
map could not be investigated. Measuring with the surrounding water phantom 
would also lead to a lower count rate than the one in this measurement. The 
initial count rate was 2.2 kcps and decreasing to 1.2 kcps for the last 
measurement.  
If there is a contribution from a Bed-overlap as seen in image 25, the additional 
activity is most likely low. 
The results also lead to thoughts of a large underestimation of the true activity in 
Table 9. If this is the case then the trend of an overestimation with the PET-
camera and an underestimation with the SPECT-camera is almost verified. In 
contrast to this is the results seen in Table 10. Perhaps the first two measurement 
preparations with 90Y cannot be taken too seriously since knowledge about the 
absolute 90Y activity into the “liver” volume is unknown. 
 
9.25 Patient evaluation 3 
 
PET results in table 12 show again an overestimation of about 20%. The SPECT 
result on the other hand once shows an underestimation of about 15 percent. 
Since a smaller amount of 90Y activity is expected in this patient’s liver than 
previous patient´s, a quick thought of activity dependence for the SPECT-system is 
                                                          
5 The results from this measurement were generated in this order, which is why it may 
seem strange to find “9.2” in the middle of the results from “10”. 
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suspected. This since the expected activity has decreased with upcoming patients, 
and also the fact that the activity quantification has become more 
underestimated.  
Table 12. Comparison of measured and true activity obtained for patient 3. 
Patient 3 Measured activity 
(MBq) 
True activity 
(MBq) 
Deviation 
PET 20 min per Bed (3 it) 761 632 +20.5% 
SPECT 30 min (50 it) 529 625 -15.4% 
 
 
 
Figure 33. 90Y distribution from PET-measurement in patient 3. 
 
Figure 34. PET-measurement in patient 3 with the threshold based segmentation applied. 
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Figure 35. SPECT-measurement from patient 3 showing the 90Y distribution. 
 
Figure 36.SPECT-measurement on patient 3 with the threshold based segmentation applied. 
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10.3 Simulated “liver” with 90Yttrium 
 
The results in Table 13 show a better quantification result for the PET-camera 
system than the SPECT camera system in table 14. The Bed overlap seems like a 
smaller problem from the PET-measurements.  
A 5% difference between the smallest overlap and the normal overlap shows that 
there is a significant impact from the sensitivity differences in the transaxial 
direction. The “normal” overlap thus seems optimized since no larger difference is 
obvious when comparing with the largest possible overlap. A difference of 0.1% 
can be ignored.  
A measurement in contrast to previous thoughts is the fact that one single Bed 
position does not overcome the results from two Bed positions. In fact the results 
show that the quantification results are about 6% better than with one Bed 
position. 
Table 13. Results from the measurements of the activity in the “liver” volume 
inserted in the water phantom. Different Bed overlap possibilities were here 
compared. 
PET 
measurement 
 
Segmentation 
threshold = 
100 000Bq/ml 
  
     
1 Bed 30 min mean activity conc. (Bq/ml) volume (litres) 
Total Activity 
(MBq) Deviation 
True activity 
1211 MBq 845509 1.73 1460 20.6% 
Normal Bed     
2 Beds a´ 30 min mean activity conc. (Bq/ml) volume (litres) 
Total Activity 
(MBq) diff (%) 
True activity 
1198 MBq 794232 1.73 1373 14.6% 
Min Bed     
2 Beds a´ 30 min mean activity conc. (Bq/ml) volume (litres) 
Total Activity 
(MBq) diff (%) 
True activity 
1182 MBq 802365 1.76 1415 19.7% 
Max Bed     
2 Beds a´ 30 min mean activity conc. (Bq/ml) volume (litres) 
Total Activity 
(MBq) diff (%) 
True activity  
982 MBq 722963 1.55 1124 14.5% 
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Table 14. Specified results from the SPECT measurement with  
the “liver” volume in the water phantom. 
SPECT    
# iterations Measured activity (MBq) True activity (MBq) Deviation 
3 1490 1227 +21.4% 
10 1533 1227 +24.9% 
20 1544 1227 +25.8% 
50 1553 1227 +26.6% 
100 1559 1227 + 27.0% 
 
 
Figure 37. Results from the SPECT measurement with the “liver” volume in the water phantom. 
 
 
Figure 38. PET-images from the simulated “liver” with 90Y (3)  
to the left and SPECT image to the right. 
 
Both the PET and SPECT image, shown in Figure 38 is visually almost equal, but 
there is difference in the quantitative values. The activity distribution is rather 
homogenous, as seen, but the results here shows that the quantitative activity 
from the SPECT camera is overestimated. The reason for this is not yet 
determined, but one reason could be that this measurement contained a source 
of high 90Y activity as compared to the other phantom setups and also when 
comparing to the patient activities. 
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Conclusion 
When comparing SPECT with PET the result in this work shows that the PET have 
the potentials of being superior to SPECT. Even though the SPECT system 
produced the best numerous quantitative results, the PET activity quantification 
result might be improved if an appropriate background noise reduction method 
can be developed and applied. The errors associated with internal dosimetry are 
of the same order as the results from SPECT and PET measurements.  
Measuring the background noise, coming from prompt gammas within the LYSO 
crystal (as shown in Figure 16), will provide a hint of the magnitude of the 
quantitative error. The spatial position of the events will be randomly distributed 
and thus not be localized at the same position during a specific measurement. 
Thus a background image cannot be applied for a simple subtraction. A 
compensation for these unwanted hotspots is of course necessary for accurate 
activity quantification or else voxels will get a larger quantitative result, thus 
leading to an apparent larger activity. If knowledge about the location of the 
voxels that is most affected by this additional background noise could be 
determined, then a spatial dependent correction factor could be determined. 
Since this has not been the case, the overestimation may be 15% each, or 100% 
for a smaller number of voxels.  
When measuring 90Y with a PET camera system sensitivity of about 5 cps/MBq, it 
is not unlikely that a contribution of counts coming from the radioactivity in the 
LYSO crystals that is in the order of 1cps, according to Bettinardi et. al, may have 
an impact on the results [22]. But if all of the additional 20% activity from the PET 
patient measurements is caused by this is not clear. It is somewhat tempting to 
say that a subtraction of 20% from the PET image would be a sufficient accurate 
result.  
 
The results from the SPECT study do not show the same consistency and thus 
seem to vary between different activity levels. More measurements would 
therefore be necessary to verify this assumption. The results indicate that high 
count rate level may overestimate the activity and that at low count rates the 
activity seems to be underestimated. 
 
On the other hand, the PET camera seems to gain from a larger 90Y activity since 
the results are somewhat improved, as shown in Table 13, compared to the 
patient results. Even though it is of the order of 5% difference it could most likely 
be traced to the larger 90Y activity and thus the better statistics in the image. Also 
the PET-system seems more stable with varying activity levels, almost stable with 
an overestimation of 20 percent, most likely due to a necessary background noise 
subtraction from the LYSO crystal elements. Once again, more experiments and 
evaluations would be required to verify these assumptions. 
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